Randomized Phase II Study Evaluating The Tolerability Of Adjuvant Docetaxel-based Chemotherapy For Completely Resected Stage IB-II Non-Small Cell Lung Cancer (NSCLC): Toledo Trial
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Success of delivery treatment; data collected during chemotherapy treatment
Paul R. Germonpre, MD PhD
Principal Investigator
Thoracic Oncology Group Antwerp
Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment
TOGA 0501
NCT00434668
December 2005
November 2010
Name | Location |
---|